leadf
logo-loader
viewBioSig Technologies, Inc.

BioSig Technologies says its PURE EP System is featured in the January issue of EP Lab Digest

The editorial, authored by the publication's editor-in-chief Bradley P. Knight highlights how the PURE EP System addresses current electrophysiology (EP) limitations through its novel hardware architecture and its proprietary signal processing software

BioSig Technologies, Inc. -
This is the latest editorial in a series of publications featuring BioSig’s PURE EP System in the industry-leading media outlets

BioSig Technologies, Inc. (NASDAQ:BSGM) announced that its PURE EP System has been featured in the January issue of EP Lab Digest.

The editorial, authored by the publication's editor-in-chief Bradley P. Knight, highlights several challenges in electrophysiology (EP), including loss of essential components of the signal during the filtering process, inadequate signal-to-noise ratio, and saturation of the signals during pacing and defibrillation.

According to Dr Knight, the need for advancements in signal recording are long overdue. Novel techniques to improve EGM signal fidelity in EP labs are imperative for the efficacy of ablation procedures.

READ: BioSig unveils partnership with Vuzix which will see the latter's M400 Smart Glasses used for remote servicing of its PURE EP System

Dr Knight highlights how the PURE EP System addresses these current limitations through its novel hardware architecture and its proprietary signal processing software. He further elaborates on the findings of the recent study titled “A novel cardiac signal processing system for electrophysiology procedures: early insights from the pure ep 2.0 study” recently presented during the European Society of Cardiology Congress 2020.

The independent, blinded reviewers rated 85% of the PURE EP signals as statistically equivalent or better based on the evaluations from 34 pairs of signals. In 35.5% of samples, the reviewers selected PURE EP data because "more signal components were visible."

“We are committed to solving unmet clinical needs through innovative technological solutions, and we are very pleased with the growing industry recognition of our PURE EP System. We look forward to expanding our physician collaborations in 2021 and reporting on more clinical insights,” commented Kenneth L. Londoner, chairman, and CEO of BioSig Technologies in a statement.

The full article can be read here: https://www.eplabdigest.com/further-optimizing-electrogram-signal-quality-ep-lab

This is the latest editorial in a series of publications featuring BioSig’s PURE EP System in the industry-leading media outlets, with the system recently highlighted in several physician user’s interviews, including the December 2020 feature interview with Rafaelle Corbisiero, M.D. and Pedram Kazemian, M.D. of Deborah Heart and Lung Center and April 2020 interview with Andrea Natale, M.D. of Texas Cardiac Arrhythmia Institute at St. David’s Medical Center.

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The company’s first product, the PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Contact the author at [email protected]

Quick facts: BioSig Technologies, Inc.

Price: 4.78 USD

NASDAQ:BSGM
Market: NASDAQ
Market Cap: $146.84 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioSig Technologies, Inc. named herein, including the promotion by the Company of BioSig Technologies, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

BioSig Technologies installs PURE EP System at Memorial Hospital,...

BioSig Technologies, Inc. (NASDAQ:BSGM) CEO Kenneth Londoner tells Proactive the group's PURE EP System has been installed and first patient cases conducted at Memorial Hospital of South Bend, part of Beacon Health System in South Bend, Indiana. Londoner says this represents the seventh...

6 days, 22 hours ago

3 min read